Explore The Latest Digital Pharma Advances From 38+ Leading Pharmaceutical Brands In 1 Inspiring Day. For Group Discount Prices, Please Call +44 (0)20 3479 2299.
New Strategies To Adapt To Digital Acceleration & Changed Customer Realities For Customer-Centric, Innovative, Multi-Channel Digital Pharma Marketing StrategiesEngage HCPs & Patients Meaningfully & Empower The Salesforce With Profitable, Compliant Digital & Channel Strategies Driven By Strong, Collaborative Internal Cultures & Savvy Data Insights To Deliver New-World Results.
A One-Day, Industry-Led Conference & Networking Event, 19th May 2021, Online. @PharmaConf

08.30 Registration, Coffee & Informal Networking
08.40 GIC Welcome, Interactive Voting Introduction & Morning Co-Chairs’ Opening Remarks
Dario Floris, Country Business Unit Head – Director, Merck
Digital Acceleration
09.10 Covid-19, Accelerated Digitalisation, Changing Behaviours – Explore The Success Stories, Lessons Learnt & Challenges Faced As Pharma’s Digital Adoption Leaps Forward
- Question the role of digital today – explore the impact, behavioural changes and learnings resulting from COVID-19 changes
- Accelerate your remote offerings or fail! How has some pharma successfully adapted physical strategies to thrive in a digital world?
- As the new reality drives change, what does the new face of digital pharma look like and has the industry changed forever – or not?
Erasmus Holm, CMO & Digital Strategy Lead, Nordics & Baltics, MSD
New Digital Strategies
09.30 Adaptable, Agile, Omnichannel Strategies That Reflect Market Dynamics & Customer Needs For Increased Personalisation, Engagement & Outstanding Results In An Unusual World
- During times of uncertainty and with changing and emerging markets, harness continuous experimentation for a more fluid strategy of accelerated learning
- Maximise personalisation and engagement with a receptive and responsive marketing team
- From patient to physician to stakeholders, involve everyone in your digital strategy to achieve the best results
Helge Tennø, Global Director Customer Experience, MSD
Engaging HCPs | Double Perspective
09.50 Decipher New HCP Expectations To Deliver The Perfect Mix Of Channels, Comms & Frequency To Create A “Business-As-Usual” Atmosphere & Drive Results
- Gain insight into the minds and changing lives of different HCPs and implement personalised comms approaches to ensure your marketing strikes the right tone
- Email? Webinar? Social media? Which method will get the best response from HCPs today and really engage them with your products?
- How much is too much? Balance the frequency of communications to ensure that email isn’t left unread
- Success stories for translating traditional marketing methods into an online world – best practices for replicating results in a purely digital world
09.50 Anastasiya Kolyasnikova, Head of Multichannel Marketing for HCPs, Sanofi
10.10 Enis Onuk, Head of Global Tail Content & Strategy, Viatris
10.30 Morning Refreshment Break With Informal Networking
Salesforce Tactics
11.00 Translate The Charm When Face-To-Face Communication Goes Purely Digital For A Ready-For-Anything Salesforce That Can Deliver Results Under Any Circumstances
- How has the role of the salesforce changed in these unprecedented times? Reflect on changes that are here to stay thanks to a more versatile team
- Help salesforces to maximise the value of online portals, apps and digital strategies to show that engagement and sales can be achieved in a virtual and physical world
- Create harmony between sales and marketing to understand how each team can help each through times of rapid change to achieve the best results for the company
- Successfully harness e-detailing with HCPs, even in a remote world
Mhari Coxon, Northern European Lead Professional & Prescription Marketing, Johnson & Johnson
Patient Centricity
11.20 Keep Patients At The Heart Of Your Digitalisation With Customer-Centric Tools That Boost Engagement & Bring Everyone On Board
- Take patients on your digital journey with easy-to-use platforms, action-driven strategies and customer-centric comms that enhance brand reputation and tackle fake news
- Offer a helping hand: encourage patients towards digital to ensure that no one is left behind
- Enable a co-creative culture across pharma, HCPs and patient advocacy groups to challenge assumptions and really put patients at the centre of your organisation
- What do patients really want? Decode the insights and create a digital experience that truly reflects the needs of patients, not HCPs
Speaker to be confirmed.
11.40 Selecting The Right Engagement & Channel Strategy In A Post-COVID-19 World
Tim Russel, VP, Head of Business Development, M3 (EU)
Digital Innovation & Tech Adoption | Panel Discussion & Q&A
11.55 Embrace Digital & Channel Innovations & Fully Embed New Technologies For Flawless, Integrated Strategies Which Engage & Sell
- Create a symbiotic relationship between digital and physical channels to strike the perfect balance and deliver the best experience for customers when nothing is normal
- Redefine your channel mix with fully integrated digital platforms that drive overall business results
- What new technologies are on the horizon and how can you create a culture of tech literacy across your company?
- When innovation is business-critical, how can you create an environment that drives new ideas for improved reach and engagement across clients?
- Go above and beyond the pharma world and find tips and tricks from industries that are well established in the digital field
Dr. Eddie Guzdar, Head of Medical – Neurology & Immunology UK & Ireland, Sanofi
Edith Schallmeiner, Director Market Development & Access – Digital, Roche
Omur Oztas, Digital Innovation Lead & GAPPAC ViiV Tech, GSK
Javier Telez, Manager Corporate Communications & Government Affairs Spain & Portugal, Teva Pharmaceuticals
12.25 Bonus Session; Reserved For Exclusive Conference Partner – Uptake Strategies
12.40 Lunch For Delegates, Speakers & Partners
Sarah Mewton, Public Affairs & Customer Relations Director, Zoetis
Mark Milton-Edwards, Head of Health Solutions – Digital, Teva Pharmaceuticals
Dirk Abeel, Global Medical Sales Director, Reckitt Benckiser
Digital Innovation & Tech Adoption | Panel Discussion & Q&A
Peer-To-Peer Discussions
13.10 Peer-To-Peer Discussions
A) E-detailing
Annelies Smits, Head of Marketing & Medical Sales – OTC & Infant Nutrition, RB
B) Telemedicine
Gianpaolo Cicchelli, Head of Sales and Marketing DDR Franchise, AstraZeneca
C) Social Media
Sarah Mewton, Public Affairs & Customer Relations Director, Zoetis
D) Digital Health: The Patient & Pharmacy Perspective
Christian Tilmann, Director M&A & Corporate Development Director Sales & Marketing, McKesson
13.40 Afternoon Co-Chairs’ Opening Remarks
Mhari Coxon, Northern European Lead Professional & Prescription Marketing, Johnson & Johnson
Virtual & Digital Customer Engagement | Panel Discussion & Q&A
13.45 Bring The Human Connection To Life Over The Screen: Embrace Virtual Engagement With Best-Practice Tips, Tools & Learnings To Maximise Virtual Platforms & Results
- From HCPs to employees, explore the different requirements around virtual engagement to get the best results from stakeholders
- Using on the ground intelligence of the health system, to precisely engage customers using the optimal blend of channels
- Try to solve the impossible task of translating the physical into the virtual – but don’t expect the same results: what is the new measure of success?
- Share and discuss the ways you have adapted to the loss of face-to-face contact: what were the success and failures and how do you continue to improve and make virtual the ‘new normal’?
- Adapt your metrics to fit a new digital world to successfully measure ROI from a variety of platforms and channels
Laurence Proust, Regional Digital Lead – Europe, Viatris
Dan McLean, Director of Marketing, Communications & Membership, Crohn’s and Colitis UK
Dr. Christian Velten, Global Head Medical Customer Experience, Roche
Jason Bonnett, Head Of Marketing, Sanofi
Jose Luis Luna, Global Brand Director, Boehringer Ingelheim
Nuno Cunha, Customer Strategy Director, The Janssen Pharmaceutical Companies of Johnson & Johnson
Christopher Meyer, France Immunology Ecosystem Head, UCB
Regulation Legal & Compliance | Panel Discussion & Q&A
14.15 Unlock The Complexity Of Compliance & Regulation, Navigate The Code & Foster Inter-Departmental Collaboration To Boost Your Digitalisation Journey
- Bring legal, marketing and sales together to encourage agile working through digitalisation and drive compliant innovation
- Create digital strategies confidently within the code: challenge risk-averse mindsets with robust internal guidelines
- Be seen as a help, not a hindrance: in times of change, how has regulation been the driver behind new processes?
- Challenge the code! How can the industry create a dialogue with regulators about creating code updates that reflect the current times?
Jolanta Wyszynska, VP Sustainability/Compliance Global BBU, Europe & Canada, Non Executive Advisor of GBS HUB Poland, AstraZeneca
Evi Mathiou, Legal, Compliance & Quality Director, Novo Nordisk
Paul Dixey, Multichannel Lead, Novartis
Sabrina Hueso, Head of Legal & Compliance Iberia, Allergan Aesthetics, an AbbVie Company
Internal Cultures, Collaboration & Digital Transformation | Double Perspective
14.40 Drive Company-Wide Digital Confidence & Collaboration With An Innovative, Digitally-Savvy Workforce As Online Becomes The New Reality
- Creating an agile and robust healthcare ecosystem with data and cloud computing, that is better able to coordinate resources and respond quickly to public health crises
- How the pandemic has allowed space for progressive technology in the fundamentals of healthcare, such as tooling and communication
- Creating an agile and robust healthcare ecosystem with data and cloud computing, that is better able to coordinate resources and respond quickly to public health crises
- How the pandemic has allowed space for progressive technology in the fundamentals of healthcare, such as tooling and communication
14.40 VIRTUAL! Cristian Perez, Head of Patient Advocacy & Communications – Oncology Business Unit – Iberia, Takeda
15.00 Amalia Graf-Czikajlo, Head of Global Brand Portfolio Optimization & Brand Management, Mylan
15.20 How Digital Technologies Can Strengthen Healthcare In A Post-Pandemic World
- Creating an agile and robust healthcare ecosystem with data and cloud computing, that is better able to coordinate resources and respond quickly to public health crises
- How the pandemic has allowed space for progressive technology in the fundamentals of healthcare, such as tooling and communication
- How the relationship between pharma and the patient is evolving and deepening, between post trial and adoption
Andrew Dunbar, General Manager, EMEA, Appnovation
15.35 Afternoon Refreshment Break With Informal Networking
Humanovation & Health
16.05 HUMANOVATION & HEALTH
- Does the age of data, digital, and virtual present an opportunity for pharma to reposition itself?
- Can pharma redefine health innovation and retake the mantle from health tech?
- Should brand strategy be designed for human impact beyond communicating the clinical product benefit?
Join us to share opinions and insights and to explore innovation for human impact.
Prodeep Bose, EVP Growth & Innovation, The BlocPartners
Data & Insights
16.20 Get Clever With Data & Gain A Deeper Understanding Of Customers To Drive Impactful Engagement Across Platforms
- Deliver a personal message in a busy online world by using data to help you accurately reflect the needs and wants of your customers
- Reflect on analytics: which channels will drive meaningful connection with customers and cut through the noise?
- Make the most of your digital platforms to collect data and use the insights they provide to tailor your next online move and boost engagement
Alexandra-Mareike Mehner, Head of Global Marketing, Communications BioMonitoring, Merck KGaA
Pharma Futures: 2021 | Panel Discussion & Q&A
16.45 Reflect On 2020 & Look Forward To 2021! How Has The Future Of Pharma Changed & What Is Necessary To Be Prepared?
- Change doesn’t stop here! Keep the level of adaptation moving forward to stay ahead of the curve and be prepared for any situation
- How will the face of pharma change in 2021? What new methodologies are on the horizon to innovate the industry and drive efficiencies?
- Look to the future for new ways to build relationships and harness engagement and finally ditch tired webinars and Zoom calls
Francesca Domenech Wuttke, Chief Digital Officer, Almirall
Oliver Gassner, Head of Digital Health Intelligence, EMEA, Bayer
David Ventura, Head of Marketing, Iberia, CSL Behring
Samuel Driessen, Senior Director External Channels & Content, Teva Pharmaceuticals
17.20 Afternoon Co-Chair’s Closing Remarks
17.30 Official Close of Conference
Plus! The Virtual Pharma Social Media Conference – Book Book Both Days For £599!
The Pharma Social Media Conference – Drive Engagement, Value & Profits With Compliant & Impactful Pharma Social Media Strategies: Compelling, Compliant, Insight-Driven Customer Engagement Strategies For Patients, HCPs, Internal & External Stakeholders • Forward-Thinking, Multi-Channel Social Media Strategies & Energising Digital Technologies • Performance Benchmarking With Robust Measurement Strategies To Secure Internal Buy-In, Investment & Support.
A One-Day, Industry-Led, Conference & Networking Event, 18th May 2021, Virtual.
A One-Day, Industry-Led, Conference & Networking Event, 18th May 2021, Virtual.

